Biochem Flashcards
Common GBA mutations
AJew: N409S (formerly N370S)
Europe: L483P (formerly L444P)
- Original nomenclature not include first 39AAs
increased aminoadipic acid semialdehyde (AASA), increased pipecolic acid
Pyridoxine Dependent Epilepsy (aminoadipic acid semialdehyde dehydrogenase)
ALDH7A1 (antiquitin)
- High P6C complexes with pyridoxal 5 phosphate (B6)
Tx: B6, folinic acid, lysine restriction, arginine supplement
DDx; PNPO deficiency
Neuroimaging for GA1
Subarachnoid collections, Sylvian fissure enlargement, BG strokes
GA1 treatment
Limit substrate: Lysine free, reduced tryptophan; carnitine (glutaryl carnitine can be excreted), ?add arginine (compete with transporter)
ACP: C5DC
Low carnitine
UOA: 3-OH glutaric acid, glutaric acid
GA1
Clinical: Macrocephaly, encephalopathy, strokes (up to age 6, natural flux of transporter decreased as brain matures)
Gene: Glutaryl-CoA dehydrogenase (GCDH)
UOA: glutaric acid, 3-OH Glutaric acid (co-elutes with 2OH-GA) Decreased carnitine
ACP: glutarylcarnitine = C5DC LOW EXCRETERS EXIST
DDx for elevated glutaric acid in urine
gut bacteria overgrowth
ketosis
SCHAD (breaks down 3OH-glutaryl-CoA),
mitochondrial,
2OH-GA in GA2,
benign GA3 (NO C5DC),
renal disease,
maternal GA1
DDx for high glycine
NKH
VPA treatment
Ketotic (PA, MMA, IVA, B-ketothiolase deficiency)
PNPO deficiency
HIE (BBB breakdown)
prolonged fasting
Lipoic acid dependent pathways
BCKDH, PDH, 2-KGDH, 2-OADH, GCS (glycine cleavage system)
AA (CSF and Plasma) : Glycine elevated, Glycine CSF/Plasma ratio > .08
NKH
Genes: glycine decarboxylase/dehydrogenase (GLDC), aminomethyltransferase (AMT), Modified lipoic acid/dihydrolipoyl dehydrogenase (GCSH)
Elevated lactate in variant forms (lipoic acid/iron-sulfur cluster disorders)
NKH treatment
Na-Benzoate - conjugate with glycine to form hippurate which can be excreted;
dextromethrophan/ketamine for NMDA antagonism; folinic acid
Cherry Red Spots
NP-A (HSM)
GM1 gangliosidossis (HSM)
GM2 gangliosidosis (no HSM)
Sialidosis
Krabbe
Farber
Metachromatic leukodystrophy
Gaucher therapies
ERT: Imiglucerase, velaglucerase, taliglucerase
SRT: miglustat, eliglustat
Fabry therapies
ERT: agalsidase-beta, agalsidase-alpha
Chaperone: migalastat
Angiokeratomas
Fabry (a-Gal) - + renal/cardiac/stroke
Fucosidosis (a-fucosidase) - FUCA - + MPS features
B-Manosidosis (ID) - MANBA - + ID/neuropathy
Schilder (NAGA - aka a-GAL-B) - +neurodegeneration
Extensive mongolian spots
MPSI, MPSII, GM1
Heparan sulfate
Heparan = Head
MPS I, II, III, VII (Brain involvement)
Dermatan sulfate
Dermatan = bone + systemic
MPS I, II, VI, VII (Bone)
Keratan sulfate
MPS VI (Bone)
A-L-Iduronidase deficiency Treatment
MPS1 Hurler
HSCT before age 2
ERT: Iaronidase
Distinguishing features of MPSII vs MPSI
X linked
No corneal clouding
Dermal pebbling
Iduronidase 2- sulfatase
Iduronidase Sulfatase def. treatment
MPS II - Hunter
ERT: Idursulfase
MPSIII diagnosis
Urine: Heparan sulfate
Gene/enzyme:
Heparan N-Sulfatase (SGSH)
Alpha-N-acetyl-glucosaminidase (NAGLU)
aceyl-coa-glucosaminide acetyltransferase (HGSNAT)
N-acetylglucosamine-6-sulfatase (GNS)
MPS IV diagnosis
Morquio
Urine: Keratan sulfate
Normal intellect
Enzyme:
N-acetylgalactosamine-6-sulfatase (GALNS)
Beta-galactosidase (GLB1, Same enzyme as GM1 gangliosidosis)
Morquio treatment
ERT: Elosulfase Alpha for type IV A
arylsulfatase B
MPS VI - Maroteaux Lamy
Enzyme: ARSB
Clinical: Normal intellect, macrocephaly, bone involvement
ERT: Galsufase
Beta glucuronidase
MPS VII (GUSB) - Sly
Hurler like
a-mannosidosis
Gene: MAN2B1 (manosidase alpha)
Clinical: MPS like
Dx: urine oligosaccharides, GAGs NORMAL
Tx: HSCT
Neuraminic acid in urine, cherry red spot
Sialidosis
Enzyme/Gene: Acid sialidase (a-neuroaminidase NEU1) - sialic acid is BOUND to other sugars since this cleaves SA
Type 1: Cherry red spot, myoclonus, decreased vision
Type 2: progressive psychomotorsymptoms, kyphosis, dysmorphic, ataxia, deafness neonatal: congenital hydrops
Dx: urine neuraminic acid, oligosaccharides
Angiokeratoma, ID, neuropathy
B mannosidosis
MANBA gened (beta mannosidase)
Dx: urine oligosaccharides
Neurodegeneration, HSM, dysostosis, angiokeratomas
Fucosidosis
FUCA1 gene (Fucosidase)
Dx: Urine oligosaccharides
Schindler disease
a-N-acetylgalactosaminidase/a-galactosidase B (NAGA)
Clin: neurodegenration, myoclonic epilepsy
Dx: Urine oligosaccharides
HSM, neurodegeneration, connective tissue changes
Aspartylglucosaminuria Aspartylglucosaminase (AGA)
Oligosaccharidosis
Dx: Urine oligos, enzyme testing
UPDGlcNAc 1-P-transferase deficiency
Mucolipidosis II and III diagnosis (I cell disease/Pseudo Hurler)
- Unable to phosphorylate mannose -> cannot get enzymes into lysosomes
- MPS like + gingival hyperplasia
Dx: Elevated urine GAGs
Normal WBC (lysosomal) enzyme activity with elevated plasma enzyme activity due to improper targeting (mannose 6 P)
Salla disease
Sialic Acid Storage
Gene: SLC7A5 (#7) in picture
Biochem: Sialin deficiency -> deficient sialic acid (N-actylneuraminic) transport out of lysosome
Clin: Hypotonia, neurodevelopmental, ataxia, spasticity, epilepsy
Dx: Free sialic acid in urine (also seen in GNE)
Sialiduria
Gene: GNE (UDP Acetylglucosamine 2 epimerase)
Myopathy OR ID, HSM, seizures
Dx: Urine sialic acid
Cystinosis
Gene: CTNS (Cystinosin)
Biochem: Lysosomal cystin transportin
Clin: FTT, HSM, myopathy, corneal crystals, thyroid, pancreas, testes, renal fanconi, renal failure
Dx: cystine in leukocytes
Tx: Cysteamine and cysteamine eye drops
Fabry urine biomarket
GL3
Acid B-galactosidase deficiency
GM1
Morquio type B
galactosialidosis
GM1 clinical subtypes
Infantile: Hydrops, neurodevelopmental arrest, HSM, dysostosis multiplex, cherry red spot, vision loss, death by 2
Juvenile: ataxia, HSP
Adult: ataxia, dystonia
Foamy histiocytes, Vacuolated lymphocytes
Low B-galactosidase activity
+ cherry red spot, spasticity, HSM
NORMAL neuraminidase assay
GM1 gangiosidosis
GLB1
- Hypotonia, DD, coarse facies, dysostosis multiplex, cherry red spot, HSM, spasticity
- Need to do neuraminidase assay when B-Galactosidase is abnormal to rule out galactosialidosis
Biochem types of GM2
Tay Sachs - Hex A
Sandhoff - Hex B (elevated urine oligos, varuolated lymph)
GM2 activator protein (both Hex A and B levels normal)
What are the 3 clinical subtypes of GM2 gangliosidosis?
Infantile: Macrocephaly, cherry red macula, neuro issues, vision loss
Juvenile: ataxia, cognitive, vision loss, seizures, weakness
Adult: ataxia, neuromuscular, neuropsych
Sphingomyelinase deficiency (SMPD)
Niemann Pick A and B
A: HSM, cherry red manula, neurological, interstitial lung disease
B: MIlder, + hyperlipidemia, normal intellect
Dx: Foam cells in bone marrow
Sea blue histiocytes, abnormal cholestane-3β-5α-6β-triol, 7-ketocholesterol (oxysterols), filipin positive
NPC
NPC1 and NPC2 (intracellular cholesterol transporter)-> cholesterol storage
- Neontal: Hydrops, cholestasis, liver failure, HSM, thrombocytopenia,
- Juvenile: neurodegeneration w/ movement do, vertical supranuclear gaze palsy, cherry rest spot (50%), epilepsy, cataplexy, dystonia
NPC clinical symptoms
Supranuclear gaze palsy, HSM, cherry red spots, neuro
NPC treatment
SRT: Miglustat
HSCT
B-galactocerebrosidase disease
Krabbe
GLAC
Clinical: WM disease, extreme irritability
Adult form: vision loss, neuropsych
Dx: CSF protein up
Tx: HSCT before 1 month?
Metachromatic leukodystrophy
ARSA (Arylsulfatase A)
Clinical: CNS, peripheral neuropathy
Dx: urine sulphatides, CSF protein
Beware Pseudo Deficiency
Pompe associations
Cardiomyopathy
Short PR
Myopathy
Pompe treatment
ERT: Aglucosidase alpha
Immune modulation if CRIM negative
Pompe diagnosis
GAA (a-glucosidase)
Urine HEX4
oligosaccharides
Vacuolated lymphocytes
NCL symptoms
Seizure
vision loss
neurodegenerative
extrapyramidal
Buffy Coat EM for ceroid storage, vacuolated lymphocytes
NCL fibroblast findings
LSD with Adrenal calcifications
Wolman Disease
Gene: LIPA (lysosomal acid lipase)
Biochem: storage of cholesterol esters and TG
Clin: Adrenal calcifications, diarrhea, steatorrhea, HSM, anemia
Dx: Elevated cholesterol
Tx: Statins, ERT - sebelipase alpha
SRTs for Gaucher, Fabry, NPC
Gaucher - eliglustat, miglustat
Fabry - migalastat
NPC - miglustat
Features of peroxisomal disorders
Dysmorphic: large fontanelle, high forehead, shallow supraorbital ridge, epicanthal folds, micrognathia
Ears: ear anomalies, hearing loss
Eyes: Retinal dystrophy, cataracts
Liver: Cholestasis/Cirrhosis
Dx of Zellweger Spectrum
VLCFA up
Plasmalogen nl or low
Phytanic acid/pristanic acid/bile acids nl or high (phytanic from diet so normal in newborns)
Pipecolic acid high
MRi findings in ZSD
Zellweger: pachypolymicorgyria neonatal
ALD: WMS
Isolated Plasmalogen low
RCDP
PEX7 (phytanic acid high, pristanic acid low)
Alkylglycerone-phosphate synthase (AGPS)
Glyceronephosphate O-acyltransferase (GNPAT)
RCDP + Hypoplasia of distal phalanges
XL RCDP - males
Gene: ARSE
Hypoplasia of distal phalanges
XL RCDP - females
Conradi Hunermann
Gene: EBP - Sterol delta-8 isomerase (male lethal)
Dx: 8-dehydrocholestrol, 8(9)-cholesterol
- Assymetric
DDx for chondrodysplasia punctata
RCDP
XL RCDP (male and female forms)
Warfarin embryopathy
Maternal SLE
Most common peroxisomal disorder
XALD
Forms of XALD
ALD, ANM, Addison’s
- all boys with adrenal insufficiency should be checked because this can precede neurological sx
XALD Diagnosis
ABCD1 gene
ATP binding cassette transporter for saturated VLCFAs into peroxisome
Disorder of Beta-Oxidation
Biochem: elevated VLCFA (C26:0)
XALD treatment
Early HCST - will take 6-9 months for new glial to be functional -> need to transplant at neurological changes
HSC gene therapy
Lorenzo’s oil (glyceryl trioleate and trierucate 4:1)
Hormone replacement - steroids
XALD in females
20% develope late onset neurological changes, adrenal problems rare
XALD brain MRI
occipital/parietal leukodystrophy
Which peroxisomal disorder has normal VLCFA
RCDP
High phytanic acid, low pristanic acid
Adult Refsum Disease
PHYH (Phytanyl CoA hydroxylase)
Clin: RP, neuropathy, ataxia, deafness, ithchyosis, skeletal, cardiac , NORMAL intellect
Dx: high phytanic acid, low pristanic acid, high CSF protein
Tx: Phytanic acid restriction, PLEX
- can be misdiagnosed as Usher
Dx: Elevated bile acids, high pristanic acid
a-methyl-acyl-CoA racemase deficiency
AMACR (isomerase that converst pristanic acid and bile acids to form needed for B-oxidation)
Adult neuropathy, encephalopathy, neonatal hepatopathy
Tx: bile acid substitution
Joint contracture, Skin nodules, Hoarse voice, neurodegeneration
- Allelic with SMA-PME
Farber disease - acid-ceramidase deficiency
ASAH
Clin: joint, skin nodules, hoarseness, neuro
Tx: HSCT
Saposin Disorders
PSAP gene (Protein cleaved into 4 small molecules required for sphingolipid hydrolysis)
A: variant Krabbe (galactosylceramidase)
B: Variant MLD (arylsulfatase A)
C: Variant Gaucher (B-glucosidase)
Combined: severe neuro/HSM
Wolf Parkinson White + pompe like LSD
Danon Disease LAMP2 (X linked) - membrane protein
Pompe-like (liver, heart, muscle) + WPW sndrome
Gaucher Buzzwords
HSM
horizontal saccades (horizonal supranuclear gaze palsy)
tissue paper macrophages
erlenmeyer flask
Hepatic/hypoglycemia GSDs
0, 1
Muscle GSDs
V, VII
Mixed GSDs
III, IV, VI, IX
GSD1 Dx
Gene: G6PC (G6Phosphatase), SLC37A4 (G6P Transporter)
- Last step of gluconeogenesis
Labs: high lactate, TG, uric acid, low glucose
glucose challenge -> fall in lactate
GSD1 features
Doll-like facies, big belly, thin extremities
Type 1B also has neutropenia/infections
Monitor: hepatic adenoma, IBD, renal function, osteopenia, anemia
GSD3 features
Cori/Forbes
Muscle and liver involvement
Milder than type 1 (debranching enzyme, so can process some glycogen)
+ Cardiomyopathy
Hepatic GSD
PAA: low ala, leu, ile, val
GSD3 - Cori
AGL (debranching enzyme)
Gluconeogenesis is funcitonal -> can use proteins for energy
Elevated LFTs, TG, lactate
Tx: same as GSD1, but add alanine (alanine -> pyruvate), fructose, and galactose
Polyglucosan accumulation, FTT, cirrhosis, fetal akinesia
Adult neurodegeneration
Andersen, GSD IV
GBE1 (branching enzyme)
- Polyglucosan = unbranched glycogen -> can accumulate in CNS too
TFF, Hepatomegaly, cirrhosis, neuromuscular, HCM
Dx: enzyme assay
Tx: Transplant
Hepatic GSDs that resolved in puberty
GSD6: Hers Disease, PYGL (Liver phosphorylase)
GSD9: Phosphorylase Kinase subunits: PHKA (X LINKED); PHKB, PHKG2 (AR)
Clinical: Hepatic GSD, mild, hepatomegaly decreases with age
Dx: Low glu, high lactate, LFTs; glucose challenge -> Rise in lactate
Tx: maintain normoglycemia
GSD0
Glycogen synthase Clin: FTT, hypoglycemia, NORMAL liver size (cannot make glycogen)
Muscle GSDs
Type 5, Mcardles: PYGM (Phosphorylase)
Type 7, Tauri: PFKM (PFK)
X linked: PHKA1 (phosphylase kinase)
Fanconi-Bickel Disease
GSD XI
GLUT2 (SLC2A2 - glucose transporter)
Clin: FTT, renal fanconi, rickets, aminoaciduria, phosphaturia, glucosuria, malabsorption, large liver AND kidneys
Most common CDG
PMM2 (CDG1a)
PMM2-CDG features
cherubic face
inverted nipple
fat pads
oringe peel skin
neuropsych
RP
dysostosis multiple
Where are N linked glycans attached
Nitrogen of Asn in part of Asn-X-Ser consensus sequence
N linked glycosylation functions
Protein stability
complex formation
leukocyte targeting/inflammation
cell-cell recognition
O linked glycosylation functions
ABO groups
antibacterial
sperm binding
cell adhesion/migration
Causes of abnormal isoelectric focusing
CDG
Transferrin polymorphisms
HFI/Galactosemia
EtOH use
Liver Disease
O linked CDG features
Muscle-eye-brain disease
GPI anchor disorders cause…
Seizures, ID
CDG1b (MPI) symptoms
protein losing enteropathy
Which CDG do you treat with mannose
CDG1b, phosphomannose isomerase (MPI)
Which CDG uses fructose, xylose, and mannose
O-linked
Hex4 can be seen in
Pompe
CDG-MOGS (hypotonia, dysmorphic)
Dolichol CDG features
bone, skin, growth issues (cholesterol pathway)
CDG treated with heart transplant
DOLK1 CDG
Wilson-like CDG without KF-rings
MPI, TMEM199, ATP6AP1 Treat with transplant
Electron movement in ETC complexes
I - NADH -> CoQ
II - FADH2 -> CoQ
III - CoQ -> Cytochrome C
IV - Cytochrome C -> O2 (pump H+)
V - Proton flow back for ATPase
A3243G, tRNA-leuUUR
MELAS mutation
high ornithine, normal ammonia, vision loss
OAT (ornithine aminotransferase deficiency)
biochem: High ornithine, low creatinine (Orn is product of AGAT, first step of creatine synthesis)
Gyrate atrophy of retina (peripheral vision loss) + cataracts
Tx: Pyridoxine, arginine restriction (after neonatal period)
PAA: high proline
UOA: high proline, OH proline, normal P5C
Hyperprolinemia type 1
PRODH (proline oxidase)
Asymptomatic, risk for schizophrenia
Heterozygotes also have high proline
PAA: high proline
UOA: high proline, OH proline, P5C
Hypreprolinemia type 2
ALDH4A1 (P5C dehydrogenase)
Epilepsy, ID, pyridoxine deficiency (P5C binds pyridoxine)
Tx: may respond to pyridoxine
High OH proline + XLE
hydroxyprolinuria
OHproline oxidase deficiency (takes place in extracellular matrix)
non-disease, but false positive for MSUD because it looks the same as Leu, Ile, and AlloIle on Mass Spec
ID, Ulcers, infections
Prolidase Deficiency
PEPD (peptidase- degrade dipeptides with N terminal Prolines)
Dx: UAA - iminodipeptides elevated
PAA: low proline, ornithine, arginine, citrulline
Hypoprolinemia
P5CS (P5C synthase deficiency)
Cataract, ID, joint laxity, hyperammonemia
P5C reductase deficiency
PYCR1 and 2
1: cutix laxa, osteopenia
2: leukodystrophy
PAA and CSF: Low Serine
PGDH, PSAT, PSPH (dehydrogenase, aminotransferase, and phosphotase)
Biochem: Serine synthesized from 3-P-glycerate (glycolysis)
May have low glycine and CSF MTHF
Clinical features of serine deficiency
Clinical:
Neu-Laxova syndrome (IUGR, severe dysmorphic features and malformations including CNS)
Infantile form: CNS/cataracts, ichthyosis
Tx: Serine supplementation
Low ASN
Asparagine synthase deficiency (ASNS)
Biochem: converts ASP -> ASN
Clinical: severe CNS, hyperekplexia
Isolated CSF Serine deficiency
SLC1A4 – ASCT1 neutral amino acid transporter
CNS Serine transporter
Hypomyelination, atrophy, spasticity
Low glutamine, normal glutamate
Glutamine synthetase deficiency (GLUL)
Hyperammonemia Severe CNS, limb defects
High glutamine, normal glutamate
Glutaminase deficiency (GLS)
Can be caused by 5’UTR expansion
DD, spasticity, seizures, cerebellar atrophy
Low glutamine, high glutamate (UAA, MRS)
Glutaminase hyperactivity (GLS)
NORMAL Glu/Gln in plasma and CSF
DD, regression, cataracts, subcutaneous nodules
Low GAA (Guanidinoacetic acid), Creatine, Creatinine; decreased Creatine/Cr
AGAT (Arginine-Glycine amidinotransferase)
GATM gene
Biochem: Arg + Glycine -> Ornithine + GAA
Clinical: ID
Tx: Creatine supplement
High GAA, low Creatine, decreased Creatine/Cr
GAMT (Guanidinoacetate methyltransferase)
Biochem: GAA + SAM -> Creatine
Clinical: ID, epilepsy, movement do
Tx. Creatine, arginine, ornithine supplement, Na Benzoate
High Creatine/Cr ratio; low Creatine in MRS
Creatine transporter
SLC6A8
X linked
ID (up to 2% of all boys with ID), epilepsy
Urine: 3-methylcrotonylglycine, 3-OH-IVA
ACP: C5OH
3MCC
Gene: MCCA, MCCB
Likely aysmptomatic, may decompensate + secondary carnitine deficiency
Homogentisic acid in urine
Alkaptonuria
HGD gene
Arthritis, ochronosis, dark coloration of urine with exposure, thyroid dysfunction, aortic stenosis, prostate stone
CAVA
Carbonic anhydrase
Biochem: water + CO2 -> bicarb (needed for CPS1, TCA cycle)
Clinical: hyperammonemia + hypoglycemia
Lab: high ammonia, lactate, ketone, glutamine, maybe carboxylate metabolites
Tx: Like UCD (carbaglu)
Urine: Elevated Cystine + Arg, Lys, Orn + nitroprusside test
Cystinuria
SLC3A1 (AR), SLC7A9 (AD)
Nephrolithiasis, may be part of deletion syndrome on 2p
Tx: hydration, urine alkinization with K-Citrate, diet, Thiols/captopril to reduce cystine in to cysteine
Treatment of Pterin defects
L-Dopa
5Oh Tryptophan (serotonin precursor)
Kuvan (tetrahydroBiopterin)
Pterin pathway
GTP -(GTPCH)-> (PTPS) -> (SR) -> BH4 -(PCD) -> BH2 -(DHPR)-> BH4
Normal Phe, Low Neopterin, Low Biopterin
GTPCH (GTP Cyclohydrolase)
GCH1 gene
Dopa Responsive Dystonia
- Homozygotes can have high phe
Normal Phe, Normal Neopterin, High Sepiapterin
SR (Sepiapterin Reductase)
SPR gene
Dopa Responsive Dystonia
- CSF neopterin can be high or normal
High Phe, High Neopterin, Low Biopterin
PTPS (6-pyruvyl tetrahydropterin syntase)
PTS gene
DD, hypotonia, epilepsy, dystonia
High Phe, High Neopterin, Low/Normal Biopterin, Primapterin (Urine)
PCD (Pterin Carbanoamine Dehydratase)
PCBD1 gene
Motor symptoms Allelic with hypomag and MODY
High Phe, normal neopterin, high biopterin
DHPR (Quinoid dihydropteridine reductase)
QDPR gene
severe CNS
Tx: Dopa, 5OH-Try, Folinic acid (secondary cerebral deficiency)
Do NOT give Kuvan (tetrahydrobiopterin)
Clinical subtypes of porphyria
Hepatic/neurovisceral
Cutaneous Blistering (normal urine PBG)
Cutaneous non-blistering (High protoporphyrin)
Hepatic Porphyria: High urine aminolevulinic acid, normal porphobilinogen
ALAD (PGB synthase)
AR - Aminolevulinic acid dehydratase prophyria
Hepatic
DDX for high ALA: tyrosinemia, lead poisoning
Hepatic Porphyria: High porphobilinogen,; no fecal findings
Acute intermittent prophyria (HMBS)
AD
Hepatic
Treatment of hepatic/neurovisceral porphyrias
1) Hemin (feedback inhibition)
2) carb load (inhibit ALAS - first step)
3) Givosiran (siRNA for ALAS)
Hepatic Porphyria: High PGB, High fecal coproporphyrin
Heriditary coprophorphyria (CPOX)
AD
Biochem -> coprophorphyrin oxidase
Hepatic and blistering
Hepatic porphyria: High PGB, high fecal copro and proto porphyrin
Porphyria Variegata (PPOX)
AD
Biochem: protoporphyrin oxidase
Hepatic and blistering
Cutaneous Blistering: high PGB, fecal coproporphyrin
Coproporphyrinogen oxidase
CPOX
Hepatic and blistering porphyria
Cutaneous Blistering: high PGB, fecal copro and protoporphyrin
propoporphyrinogen oxiddase
PPOX
Hepatic and blistering porphyria
Porphyria Cutanea Tarda Tx
Hydroxychloroquine and phlebotomy
Biomarker for porphyrias
Hepatic: ALA high during episodes, high urine PBG (except for ALAD)
Blistering: normal uring PBG
Non blistering: RBC protoporphyrin
Cutaneous Blistering: normal PGB, coproporphyrin > uro/carboxylated porphyrins
Congenital erythorpoietic porphyria (UROS)
URO synthetase
Severe skin + corneal ulceration + teeth discoloration + red urine + hemolytic anemia
Cutaneous Blistering: normal PGB, uro/carboxylated porphyrins > coproporphyrin
Porphyria Cutanea Tarda (AD)
(UROD) - dehydrogenase
Adult onset, most common porphyria (can be secondary)
Hepatoerythropoetic porphyria (AR) - Homozygotes have severe infantile presentation of skin, teeth + hemolytic anemia just like UROS (previous enzyme in pathway)
Non-blistering porphyria: high protoporphyrin (RBC, fecal), RBC zinc < 15%
erythropoetic protoporphyria FECH (ferrochelolase)
Non-blistering porphyria: high protoporphyrin (RBC, fecal), RBC zine 15-50%
X-linked protoporphyria ALAS (ALA synthase) hyperactivity
- Deficiency - X linked siderloblastic anemia
Haem Metabolism pathway
Glycine + succinyl CoA -(ALAS)-> :Non-blistering
ALA -(ALAD)-> :Hepatic
Porphobilinogen -(HMBS)-> :Hepatic
Hydroxymethylbilane -(UROS)-> :Blistering + hemolytic
Urophyrinogen -(UROD)-> :Blistering
Coproporphyrinogen -(CPOX)-> :Hepatic/Blistering
Protoporphyrinogen -(PPOX)-> :Hepatic/Blistering
Protoporphyrin -(FECH) -> :Non-blistering Haem
What are the protoporphyrias
non-blistering cutaneous porphyrias (Sun -> Pain)
ALAS hyperactivity (first step of pathway)
FECH (Ferrochetolase - Last step of haem synthesis)
Name the 2 ALA - synthase diseases
X linked protoporhyria (Hyperactivity)
X linked sideroblasatic anemia (deficiency)
Which porphyrias are both hepatic and blistering
Hereditary Coproporphyria (CPOX) and Variegate porphyria (PPOX)
- Both caused by oxidase deficiencies
- Final 2 steps of pathway before ferrochetolase
What are the main products of Trytophan degradation?
Niacin (B3), Melatonin, Serotonin
UAA: High Ala, Ser, Thr, His
PAA: Low Ala, Ser, Thr, His
Hartnup SLC6A19 (B0AT1 protein)
Neutral AA transporter
Dermatitis, Diarrhea, Dementia (Pellagra like) + Cerebellar Most asymptomatic (dietary niacin?)
How to tell apart Hartnup from Fanconi or generalized aminoaciduria on UAA?
Gly, proline, Met are normal in Hartnup
high in Fanconi/aminoaciduria
Trp transporter defect
Blue diaper syndrome
Bacterial convert trp to indole –> blue eye
UOA: Xanthurenic acid
Kynureninase and HAAO deficiency
Biochem: Trp -X-> niacin VACTERL-like,
hyperphalangism (extra bone in prox. middle phalanges)
Hypertryptophanemia
Tryptophan Dioxygenase Deficiency (TDO)
non-disease
Tx: nicotinic acid (niacin) supplement
Nicotinamide nucleotide adenylyltransferase 1 (NMNAT1) deficiency
Leber congenital amaurosis
Congenital coloboma, optic atrophy NAD biosynthesis defect
ACP: Elevated C10:2
Dienoyl-Coa reductase (DECR)
NADK2
Defect in NAD phosphorylation to NADH
CNS: Movement do, seizure, hypotonia, optic atrophy
PAA: high lysine
Hydrated NAD (NADHX) repair defects
NAXD (dehydrogenase) and NAXE (epimerase)
Febrile triggered - neurodegeneration, blistering skin lesions, cardiac
2 causes of elevated Histidine
Histidinemia - HAL gene, imidazolepyruvic acid in urine
Urocanic aciduria (UROC1 gene)
Both non-disease
What 3 AA make up glutathione
Glutamate, Cysteine, Glycine
AKA: gamma-glytamylcysteinylglycine
Low glutathione, hyperaminoaciduria, normal 5-oxoproline
Gamma-glutamylcysteine synthetase deficiency
Part of glutathione synthesis
Hemolytic anemia + ?neurodegeneration
Tx: Avoid triggers (like G6PD), Vit C + E
High urine and plasma glutathione
gamma-glutamyl transpeptidase deficiency (First step of glutathione degradation)
GGT1 gene
ID, psychosis
High cystinylglycine
Dipeptidase deficiency
Biochem: Glutathione breakdown pathway
Glutathione levels normal
CNS, neuropathy, deafness
Low glutathione, high 5-oxoproline
Glutathione synthetase deficiency
GSS gene Hemolytic anemia + neurodegeneration
Tx: Vit E, N-acetylcystine, avoid G6PD triggers
DDx for high 5-oxoproline
Glutathione synthetase deficiency (Hemolysis + CNS)
5-oxoprolinase deficiency (OPAH gene, non disease?)
Acute metabolic decompensation (mito, PA, urea cycle)
SJS
medications
prematurity
Nutritional
Rotting fish odor
Trimethylaminuria (FMO3 or DMGDH)
Biochem: Choline degradation pathway
Dx: Choline loading protocol (measure TMA and TMA-oxide in urine before and after)
Tx; Dietary restriction (milk, choline, lecithin, seafood)
DDx Elevated sarcosine (PAA)
Sarcosinemia (SARDH) -> causes false elevation in Creatinine measurements -> false positive for renal failure (BUN normal)
GA2
Folate deficiency
Choline breakdown products
1) Choline -> Betaine -> Dimethylglycine -> Sarcosine -> Glycine
2) Choline -> Trimethylamine -> TMA-oxiide
Treatment for GSD 1
Glycosade (modifined cornstarch) or uncooked cornstarch Liver/kidney transplant
GSD V vs GSD VII distinguishing characteristic
GSD V -> second wind
GSD VII -> Out of wind (F6P inhibition of FAO), golyglucosan storage (high G6P activates glycogen synthase, mild erythrocytosis and hemolysis (gluconeogenesis defect affecting RBCs)
5 Coenzymes for PDH complex
1 - Thiamine (TPP)
2 - Flavin (FAD)
3 - Lipoic acid
4 - CoA
5 - Nicotinamide (niacin)
3 steps of pyrimidine catabolism
Uracil/Thymine —> B-alanine/B-aminoisobutyric acid
1) dihydropyrimidine dehydrogenase
2) dihydropyrimidase
3) B-ureidopropionase
Hight urine thiamine and uracil
Dihydropyrimidine dehydrogenase deficiency
Gene: DPYD
- asymptomatic vs seizures and ID
- 5FU toxicity
UOA: high dihydrouracil/dihydrothymine, uracil, thymine
dihydropyrimidinase deficiency
Gene: DPYS
- asymptomatic vs seizures and DD -
5FU toxicity
high ureidopropionate, B-alanine, and ureidoisobutyrate (normal-high dihydrouracil, dihydrothymine, uracil, thymine)
B-ureidopropinase deficiency (B-alanine synthase deficiency)
gene: UPB1
- Asymptomatic vs dystonia
- 5FU toxicity
CSF AA: high GABA, B-alanine, homocarnosine
GABA transaminase Deficiency gene ABAT
Biochem: GABA -> succinate semialdehyde
Clin: epileptic encephalopathy, macrosomia; increased growth
Avoid vigabatrin
UOA: 4-hydroxybutyric acid (Gamma hydroxy-butyrate)
Succinic Semialdehyde Dehydrogenase
SSADH gene: ALDH5A1
Clin: Slowly progressive neuropsych, movement do, seizures
MRI: BG/WM disease
- Avoid VPA
High carnosine
Carnosinase deficiency - incidental finding - ?homocarnosinosis
Creatine synthesis pathway
Arg + Glycine - (AGAT) -> ornithine + Guanadinoacetate - (GAMT) -> creatine -(SLC6A8 transporter)-> creatinine
CSF: High 3OMD, low 5-HIAA, low HVA, low MHPG, low VMA
AADC
DDC gene
biochem -> converts 5-OHT and DOPA into serotonin and Dopamine
- urine profile may be opposite of CSF
Treatment for AADC
Pyridoxine (B6),
MAOi, agonists
- Do NOT give DOPA or 5-OHT
CSF: Low HVA, low MHPD, low VMA, low 3OMD; normal 5-HIAA
Tyrosine hydroxylase (TH)
Biochem: tyrosine -> DOPA
- Movement DO, encephalopathy
- Dopa responsive
CSF: Low MHPG, low VMA
Dopamine B- hydroxylase (DBH)
Biochem: Dopamine -> Norepi
- Dysautonomia
Tx - droxidopa
CSF: Low MHPG, VMA, 5HIAA, and HVA; normal 3OMD
MAO deficiency
MAOA (X linked), MAOB
Clin: Serotonin + carcinoid features; atonic episodes,
Dx - Elevated urine/CSF neurotransmitters (serotonin, tyramine, normetanephrine, etc)
Tx: Diet
What neurotransmitter produces the following metabolites? 1) HVA 2) 5HIAA 3) MHPG 4) VMA 5) 3OMD
1) Dopamine
2) Serotonin
3) Norepi
4) Epinephrine
5) L DOPA
CSF: High HVA (isolated)
Dopamine Transporter (presynaptic uptake defect) SLC6A3
Clinical: Movement do
HVA/5HIAA ratio >5
CSF: normal
Urine: high HVA and 5HIAA, low dopamine and norepinephrine
VMAT2 (SLC18A2)
Biochem: defective vesicular loading
Clin: Movement do
Tx: Dopamine receptor agonist (pramipexole) -
WORSE with L DOPA (dopamine does not make it into vesicle)
GSDs by ascending number
0 - Glycogen synthase (Hepatic, No HSM)
I - G6P Phosphotase (Hepatic)
II - Acid Maltase (Muscle) - cardiac involvement
III - Debranching (Mixed) - cardiac involvement
IV - Branching (Mixed) - cardiac involvement
V - Myophosphorylase (Muscle) - 2nd wind
VI - Liver Phosphorylase (Mixed) - mild
VII - Muscle PFT (Muscle) - no wind
IX - Liver Phosphorylase Kinase (Mixed) - mild
Hurler-like MPS and their enzymes
“-Ronidase”
MPS I - a L iduronidase
MPS II - Idurotnate sulfatase (X linked)
MPS VII - B-Glucoronidase
Primary CNS MPS + enzymes
“Heparan and -glucosaminde”
MPS III
A: Hepran sulfatase (SGSH)
B: N acetylglucosamidase (NAGLU)
C: acetyl-Coa glucosaminide acyltransferase (HGSNAT)
D: N-acetylglucosamine 6 sulfafase (GNS)
Primary Bone MSP and enzymes
“galacto-“
MPS IV and VI
IV A - galactose - 6- sulfatase (GALNS)
IV B - B- Galactosidase
VI - N-acetylgalactosamine 4 sulfatase (arylsulfatase B)
PAA: Low cit, high gln
Urine: low orotic acid
CPS1 or NAGS
CPS1 = rate limiting step
Severe neonatal UCD
N gets funneled into glutamine synthesis
- NAGS can be replaced by carbamylglutamate (Carboglu)
PAA: High Gln, Low Cit/Arg
Urine: Orotic acid high
OTC
X linked - 2/3 inherited, 1/3 de novo
Zinc-required for function
PAA: High gln, High cit, low Arg
Urine: high orotic acid
Citrullinemia type I
ASS
Arginosuccinate synthase
Milder UCD
PAA: High Arginosuccinic acid, high Cit, low Arg
Urine: high orotic acid, high arginosuccinic acid
Arginosuccinic aciduria
ASL (Lyase)
+ Trichorexis Nodosa
Urine arginosuccinic acid is more sensitive than plasma
PAA: high Arg
Urine: high orotic acid
Arginase Deficiency
ARG1 gene
Mild hyperammonemia, chronic sx
High Arg -> high GAA (creatine synthesis) -> ID, seizures, neuropathy in 2nd decade
- May be ornithine deficient
PAA: High Citrulline, may be high Thr/ Met/ Tyr
Citrin Deficiency (Citrullinemia type 2)
Aspartate transporter (SLC25A13)
Neonate: cholestatis, hepatomegaly
Juvenile/Adult: hyperammonemia, dyslipidemia, FTT
Tx: REPLACE ASP with high protein/high fat/low carb diet
PAA: High ornithine, normal Cit/Arg, high glutamine (ammonia)
UOA: high ornitine, homocitrulline
HHH (Hyperammonemia, Hyperornithinemia, Homocitrulline)
SLC25A15 - ornithine transporter
Ammonia > Gln levels
- Can cause coagulopathy
Tx: ammonia scavengers, cit supplement, protein restriction
DDx for hyperornithine
OAT (gyrate atrophy/eye changes) - treat with pyridoxine, arginine restriction after infancy
HHH (Ornithine transporter) - treat with citrulline supplement, protein restriction, ammonia scavengers